Additionally, the increase in IL-1 in AD patients might promote an increase in p38-MAP kinase activity, which could lead to Tau hyperphosphorilation (Sheng et al., 2000; Li et al., 2003). The gene discussed is MAPT; the disease is Alzheimer disease.